FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ian Davis

Research Profile

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Jeremy M Simon; Ian Davis; Paul G Giresi; Jason D Lieb
A detailed protocol for formaldehyde-assisted isolation of regulatory elements (FAIRE).
Don W Coulter; Ian Davis; Allison M Deal; Wasiuddin A Khan; Andrew W McFadden; Billie M Moats-Staats; Javier Oesterheld; Jai Patel; Scott V Smith; Christine M Walko; Arlene S Bridges; Julie Blatt
Valproic acid reduces the tolerability of temsirolimus in children and adolescents with solid tumors.
Andrew J Wagner; Feng Chai; Edwin Choy; Ian Davis; Steven G Dubois; James Geller; John M Goldberg; David Hogg; Ian Judson; Alberto Pappo; Lee Rosen; Brian Schwartz; Neil Senzer; Carol Waghorne; George D Demetri
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ian Davis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jeremy M Simon; Ian Davis; Paul G Giresi; Jason D Lieb
A detailed protocol for formaldehyde-assisted isolation of regulatory elements (FAIRE).
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2013;Chapter 21():Unit21.26.
2013: Don W Coulter; Ian Davis; Allison M Deal; Wasiuddin A Khan; Andrew W McFadden; Billie M Moats-Staats; Javier Oesterheld; Jai Patel; Scott V Smith; Christine M Walko; Arlene S Bridges; Julie Blatt
Valproic acid reduces the tolerability of temsirolimus in children and adolescents with solid tumors.
Anti-cancer drugs 2013;24(4):415-21.
2012: Andrew J Wagner; Feng Chai; Edwin Choy; Ian Davis; Steven G Dubois; James Geller; John M Goldberg; David Hogg; Ian Judson; Alberto Pappo; Lee Rosen; Brian Schwartz; Neil Senzer; Carol Waghorne; George D Demetri
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial.
Cancer 2012;118(23):5894-902.
2012: Mukund Patel; Jeremy M Simon; Sam B Wu; Michael D Iglesia; Jason D Lieb; Andrew W McFadden; Ian Davis
Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription.
Genome research 2012;22(2):259-70.
2011: Mary E Resseguie; Kerry-Ann da Costa; Joseph A Galanko; Mukund Patel; Ian Davis; Steven H Zeisel
Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction.
The Journal of biological chemistry 2011;286(2):1649-58.
2010: Ian Davis; Andrew W McFadden; Yixiang Zhang; Angela Coxon; Teresa L Burgess; Andrew J Wagner; David E Fisher
Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma.
Cancer research 2010;70(2):639-45.
2009: Wei Sun; Michael J Buck; Mukund Patel; Ian Davis
Improved ChIP-chip analysis by a mixture model approach.
BMC bioinformatics 2009;10():173.
2007: Ian Davis; David E Fisher
MiT transcription factor associated malignancies in man.
Cell cycle (Georgetown, Tex.) 2007;6(14):1724-9.
2007: Mohammed Sebaihia; Michael W Peck; Nigel P Minton; Nicholas R Thomson; Matthew T G Holden; Wilfrid J Mitchell; Andrew T Carter; Stephen D Bentley; David R Mason; Lisa Crossman; Catherine Paul; Alasdair Ivens; Marjon H J Wells-Bennik; Ian Davis; Ana M Cerdeño-Tárraga; Carol Churcher; Michael A Quail; Tracey Chillingworth; Theresa Feltwell; Audrey Fraser; Ian Goodhead; Zahra Hance; Kay Jagels; Natasha Larke; Mark Maddison; Sharon Moule; Karen Mungall; Halina Norbertczak; Ester Rabbinowitsch; Mandy Sanders; Mark Simmonds; Brian White; Sally Whithead; Julian Parkhill
Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes.
Genome research 2007;17(7):1082-92.
2007: Masumi Tsuda; Ian Davis; Pedram Argani; Neerav Shukla; Gaël G McGill; Makoto Nagai; Tsuyoshi Saito; Marick Laé; David E Fisher; Marc Ladanyi
TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition.
Cancer research 2007;67(3):919-29.
2006: Ian Davis; Jessica J Kim; Fatih Ozsolak; Hans R Widlund; Orit Rozenblatt-Rosen; Scott R Granter; Jinyan Du; Jonathan A Fletcher; Christopher T Denny; Stephen L Lessnick; W Marston Linehan; Andrew L Kung; David E Fisher
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.
Cancer cell 2006;9(6):473-84.
2005: Toru Mukohara; Gabriel Civiello; Ian Davis; Michele L Taffaro; James Christensen; David E Fisher; Bruce E Johnson; Pasi A Janne
Inhibition of the met receptor in mesothelioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8122-30.
2005: Pedram Argani; Marick Laé; Brian Hutchinson; Victor E Reuter; Margaret H Collins; John P Perentesis; John E Tomaszewski; John S J Brooks; Geza Acs; Julia A Bridge; Sara O Vargas; Ian Davis; David E Fisher; Marc Ladanyi
Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR.
The American journal of surgical pathology 2005;29(2):230-40.
2005: Arlo J Miller; Carmit Levy; Ian Davis; Ehud Razin; David E Fisher
Sumoylation of MITF and its related family members TFE3 and TFEB.
The Journal of biological chemistry 2005;280(1):146-55.
2003: Wade E Huber; E Roydon Price; Hans R Widlund; Jinyan Du; Ian Davis; Michael Wegner; David E Fisher
A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes.
The Journal of biological chemistry 2003;278(46):45224-30.
2003: Ian Davis; Bae-Li Hsi; Jason Arroyo; Sara O Vargas; Y Albert Yeh; Gabriela Motyckova; Patricia Valencia; Antonio R Perez-Atayde; Pedram Argani; Marc Ladanyi; Jonathan A Fletcher; David E Fisher
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(10):6051-6.
2001: Sara O Vargas; Christopher A French; P N Faul; Jonathan A Fletcher; Ian Davis; Paola Dal Cin; Antonio R Perez-Atayde
Upper respiratory tract carcinoma with chromosomal translocation 15;19: evidence for a distinct disease entity of young patients with a rapidly fatal course.
Cancer 2001;92(5):1195-203.
1999: Ian Davis; Henry H Bernstein
Neonatal jaundice, animal-based injuries, and immunizations.
Current opinion in pediatrics 1999;11(4):367-73.
1998: Ian Davis; Henry H Bernstein
Neonatal jaundice, animal-based injuries, and immunizations.
Current opinion in pediatrics 1998;10(4):453-8.
1994: Ian Davis; Lester F Lau
Endocrine and neurogenic regulation of the orphan nuclear receptors Nur77 and Nurr-1 in the adrenal glands.
Molecular and cellular biology 1994;14(5):3469-83.
1993: Ian Davis; T G Hazel; R H Chen; J Blenis; Lester F Lau
Functional domains and phosphorylation of the orphan receptor Nur77.
Molecular endocrinology (Baltimore, Md.) 1993;7(8):953-64.
1991: Ian Davis; T G Hazel; Lester F Lau
Transcriptional activation by Nur77, a growth factor-inducible member of the steroid hormone receptor superfamily.
Molecular endocrinology (Baltimore, Md.) 1991;5(6):854-9.
1991: T G Hazel; R Misra; Ian Davis; M E Greenberg; Lester F Lau
Nur77 is differentially modified in PC12 cells upon membrane depolarization and growth factor treatment.
Molecular and cellular biology 1991;11(6):3239-46.